HK1254672A1 - 治療痛覺過敏的方法 - Google Patents
治療痛覺過敏的方法Info
- Publication number
- HK1254672A1 HK1254672A1 HK18113653.1A HK18113653A HK1254672A1 HK 1254672 A1 HK1254672 A1 HK 1254672A1 HK 18113653 A HK18113653 A HK 18113653A HK 1254672 A1 HK1254672 A1 HK 1254672A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- treating hyperalgesia
- hyperalgesia
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562267144P | 2015-12-14 | 2015-12-14 | |
PCT/US2016/066601 WO2017106306A1 (en) | 2015-12-14 | 2016-12-14 | Methods of treating hyperalgesia |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1254672A1 true HK1254672A1 (zh) | 2019-07-26 |
Family
ID=59057459
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18110996.3A HK1251472A1 (zh) | 2015-12-14 | 2018-08-27 | 治療痛覺過敏的方法 |
HK18113653.1A HK1254672A1 (zh) | 2015-12-14 | 2018-10-24 | 治療痛覺過敏的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18110996.3A HK1251472A1 (zh) | 2015-12-14 | 2018-08-27 | 治療痛覺過敏的方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US10588889B2 (zh) |
EP (1) | EP3389657A4 (zh) |
JP (2) | JP6991993B2 (zh) |
KR (1) | KR20180093930A (zh) |
CN (1) | CN108366997A (zh) |
AU (1) | AU2016372028B2 (zh) |
CA (1) | CA3007020A1 (zh) |
HK (2) | HK1251472A1 (zh) |
IL (2) | IL259992B (zh) |
WO (1) | WO2017106306A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3290415T3 (pl) | 2011-03-23 | 2021-07-19 | Trevena, Inc. | Ligandy receptora opioidowego oraz sposoby ich stosowania i wytwarzania |
AU2016372028B2 (en) * | 2015-12-14 | 2022-02-17 | Trevena, Inc. | Methods of treating hyperalgesia |
CA3008637A1 (en) * | 2015-12-17 | 2017-06-22 | Trevena, Inc. | Combinations of opioid receptor ligands and cytochrome p450 inhibitors |
CN115403570A (zh) * | 2017-09-18 | 2022-11-29 | 上海华汇拓医药科技有限公司 | μ-阿片受体激动剂及其制备方法和在医药领域的应用 |
WO2020147848A1 (zh) * | 2019-01-17 | 2020-07-23 | 上海海雁医药科技有限公司 | 三环取代的氧杂螺环衍生物、其制法与医药上的用途 |
US20230147833A1 (en) * | 2020-01-17 | 2023-05-11 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Optically pure oxaspiro-substituted pyrrolopyrazole derivative, preparation method therefor and pharmaceutical use thereof |
WO2021143801A1 (zh) | 2020-01-17 | 2021-07-22 | 上海海雁医药科技有限公司 | 氮杂双环取代的氧杂螺环衍生物、其制法与医药上的用途 |
CN113214264B (zh) * | 2020-01-21 | 2022-08-09 | 上海海雁医药科技有限公司 | 二氢吡咯并五元杂芳基取代的氧杂螺环衍生物、其制法与医药上的用途 |
CN114269738B (zh) * | 2020-08-10 | 2023-09-29 | 成都苑东生物制药股份有限公司 | 一种mor受体激动剂化合物、制备方法及其用途 |
EP4265604A1 (en) | 2020-12-29 | 2023-10-25 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd | Oxaspiro substituted pyrrolopyrazole derivative, intermediate thereof, and preparation method therefor |
EP4361154A1 (en) | 2021-07-13 | 2024-05-01 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Pharmaceutically acceptable salt of mor receptor agonist, and polymorph thereof and use thereof |
WO2023030319A1 (zh) * | 2021-08-31 | 2023-03-09 | 天地恒一制药股份有限公司 | 阿片受体激动剂及其制备方法和用途 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5825980B2 (ja) | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | サイクリックヌクレオチドの定量法 |
US4602035A (en) | 1983-12-07 | 1986-07-22 | Hoechst-Roussel Pharmaceuticals Inc. | Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines |
US5223530A (en) * | 1990-07-31 | 1993-06-29 | Sri, International | Arylcycloalkanepolyalkylamine ligands |
US5401629A (en) | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
WO1996005166A1 (fr) | 1994-08-11 | 1996-02-22 | Yamanouchi Pharmaceutical Co., Ltd. | Derive d'amine substitue et composition medicamenteuse le contenant |
DE69635048T2 (de) | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
US6071918A (en) | 1999-07-21 | 2000-06-06 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
GB0130261D0 (en) | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Lactams as tachykinin antagonists |
TW200307539A (en) | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
CN1305852C (zh) | 2002-09-19 | 2007-03-21 | 伊莱利利公司 | 作为阿片受体拮抗剂的二芳基醚 |
BRPI0415165A (pt) | 2003-10-01 | 2007-01-09 | Adolor Corp | composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem |
WO2007041341A2 (en) | 2005-09-29 | 2007-04-12 | The Trustees Of Columbia University In The City Of New York | Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof |
US20070203224A1 (en) | 2006-01-09 | 2007-08-30 | University Of Southern California | Small-molecules for treating cancer and abnormal cell proliferation disorders |
US7645767B2 (en) | 2006-08-31 | 2010-01-12 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
JP2010508358A (ja) | 2006-11-01 | 2010-03-18 | ブリストル−マイヤーズ スクイブ カンパニー | グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用 |
WO2008057856A2 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
WO2009018169A1 (en) | 2007-07-27 | 2009-02-05 | Auspex Pharmaceuticals, Inc. | Substituted cyclohexanols |
MX2010009955A (es) | 2008-03-27 | 2010-09-30 | Gruenenthal Gmbh | Derivados de ciclohexano espirociclicos sustituidos. |
EP2415471A1 (en) * | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
FR2967672B1 (fr) | 2010-11-22 | 2012-12-28 | Sanofi Aventis | Derives de nitrobenzothiazoles, leur preparation et leurs applications therapeutiques |
PL3290415T3 (pl) * | 2011-03-23 | 2021-07-19 | Trevena, Inc. | Ligandy receptora opioidowego oraz sposoby ich stosowania i wytwarzania |
AU2016372028B2 (en) * | 2015-12-14 | 2022-02-17 | Trevena, Inc. | Methods of treating hyperalgesia |
-
2016
- 2016-12-14 AU AU2016372028A patent/AU2016372028B2/en active Active
- 2016-12-14 US US15/378,930 patent/US10588889B2/en active Active
- 2016-12-14 CA CA3007020A patent/CA3007020A1/en active Pending
- 2016-12-14 JP JP2018549425A patent/JP6991993B2/ja active Active
- 2016-12-14 WO PCT/US2016/066601 patent/WO2017106306A1/en active Application Filing
- 2016-12-14 EP EP16876556.8A patent/EP3389657A4/en active Pending
- 2016-12-14 CN CN201680072936.2A patent/CN108366997A/zh active Pending
- 2016-12-14 KR KR1020187016651A patent/KR20180093930A/ko not_active Application Discontinuation
-
2018
- 2018-06-13 IL IL259992A patent/IL259992B/en active IP Right Grant
- 2018-08-27 HK HK18110996.3A patent/HK1251472A1/zh unknown
- 2018-10-24 HK HK18113653.1A patent/HK1254672A1/zh unknown
-
2020
- 2020-02-26 US US16/801,567 patent/US20210023043A1/en not_active Abandoned
-
2021
- 2021-03-07 IL IL281293A patent/IL281293A/en unknown
- 2021-07-21 JP JP2021120116A patent/JP2021169521A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1251472A1 (zh) | 2019-02-01 |
AU2016372028A1 (en) | 2018-07-12 |
EP3389657A4 (en) | 2019-08-07 |
AU2016372028B2 (en) | 2022-02-17 |
CA3007020A1 (en) | 2017-06-22 |
JP2019504113A (ja) | 2019-02-14 |
US10588889B2 (en) | 2020-03-17 |
IL281293A (en) | 2021-04-29 |
JP6991993B2 (ja) | 2022-01-13 |
US20170333385A1 (en) | 2017-11-23 |
IL259992A (en) | 2018-07-31 |
KR20180093930A (ko) | 2018-08-22 |
CN108366997A (zh) | 2018-08-03 |
JP2021169521A (ja) | 2021-10-28 |
US20210023043A1 (en) | 2021-01-28 |
WO2017106306A1 (en) | 2017-06-22 |
IL259992B (en) | 2021-03-25 |
EP3389657A1 (en) | 2018-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251408A1 (zh) | 治療癌症的方法 | |
ZA201804227B (en) | Methods of treating cancer | |
IL281293A (en) | Methods of treating hyperalgesia | |
IL259783A (en) | Methods of treatment of malignant diseases | |
IL257252A (en) | Methods for treating fgf21-related disorders | |
GB201701673D0 (en) | Methods of well treatment | |
HK1248552A1 (zh) | 使用川地匹坦的治療方法 | |
IL252296A0 (en) | Methods for treating multiple sclerosis | |
IL256207B (en) | Methods for treating multiple sclerosis | |
HK1246655A1 (zh) | 治療不育的方法 | |
HK1259347A1 (zh) | 治療結腸炎的方法 | |
GB201410116D0 (en) | Method of treatment | |
HK1255221A1 (zh) | 使用卡多曲組合物進行治療的方法 | |
GB201604627D0 (en) | Improved method of FT-IMS | |
IL253028A0 (en) | treatment method | |
GB201416832D0 (en) | Methods of treatment | |
HK1249866A1 (zh) | 用他塞利昔布進行治療的方法 | |
HK1244692A1 (zh) | 治療纖維化的方法 | |
IL255498A (en) | Treatment of pruritus | |
GB201602802D0 (en) | Method of treatment | |
GB201512139D0 (en) | Methods of treatment | |
PT3261661T (pt) | Menotropina para tratar a infertilidade | |
GB201511017D0 (en) | Method of treatment | |
GB201421980D0 (en) | Method of treatment | |
GB201421982D0 (en) | Method of treatment |